Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

September 5, 2028

Study Completion Date

September 5, 2028

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL

CD117 CAR T-cells

Each subject receive CD117 CAR T-cells by intravenous infusion

Trial Locations (1)

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors

collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER